The murine gene p27Kip1 is haplo-insufficient for tumour suppression

被引:666
作者
Fero, ML
Randel, E
Gurley, KE
Roberts, JM
Kemp, CJ
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[2] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA
关键词
D O I
10.1038/24179
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
p27(Kip) is a candidate human tumour-suppressor protein, because it is able to inhibit cyclin-dependent kinases and block cell proliferation(1-5). Abnormally low levels of the p27 protein are frequently found in human carcinomas, and these low levels correlate directly with both histological aggressiveness and patient mortality(6-10). However, it has not been possible to establish a causal link between p27 and tumour suppression, because only rare instances of homozygous inactivating mutations of the p27 gene have been found in human tumours(11-14). Thus, p27(Kip1) does not fulfil Knudson's 'two-mutation' criterion for a tumour-suppressor gene(15). Here we show that both p27 nullizygous and p27 heterozygous mice are predisposed to tumours in multiple tissues when challenged with gamma-irradiation or a chemical carcinogen. Therefore p27 is a multiple-tissue tumour suppressor in mice. Molecular analyses of tumours in p27 heterozygous mice show that the remaining wild-type allele is neither mutated nor silenced. Hence, p27 is haplo-insufficient for tumour suppression. The assumption that null mutations in tumour-suppressor genes are recessive excludes those genes that exhibit haplo-insufficiency.
引用
收藏
页码:177 / 180
页数:4
相关论文
共 30 条
  • [1] DIAGONAL CUBIC EQUATIONS .2.
    BAKER, RC
    [J]. ACTA ARITHMETICA, 1989, 53 (03) : 217 - 250
  • [2] BOUFFLER SD, 1995, CANCER RES, V55, P3883
  • [3] THYMOCYTE APOPTOSIS INDUCED BY P53-DEPENDENT AND INDEPENDENT PATHWAYS
    CLARKE, AR
    PURDIE, CA
    HARRISON, DJ
    MORRIS, RG
    BIRD, CC
    HOOPER, ML
    WYLLIE, AH
    [J]. NATURE, 1993, 362 (6423) : 849 - 852
  • [4] Requirement of p27(Kip1) for restriction point control of the fibroblast cell cycle
    Coats, S
    Flanagan, WM
    Nourse, J
    Roberts, JM
    [J]. SCIENCE, 1996, 272 (5263) : 877 - 880
  • [5] HOMOZYGOSITY OF CHROMOSOME 13 IN RETINOBLASTOMA
    DRYJA, TP
    CAVENEE, W
    WHITE, R
    RAPAPORT, JM
    PETERSEN, R
    ALBERT, DM
    BRUNS, GAP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (09) : 550 - 553
  • [6] Esposito V, 1997, CANCER RES, V57, P3381
  • [7] A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
    Fero, ML
    Rivkin, M
    Tasch, M
    Porter, P
    Carow, CE
    Firpo, E
    Polyak, K
    Tsai, LH
    Broudy, V
    Perlmutter, RM
    Kaushansky, K
    Roberts, JM
    [J]. CELL, 1996, 85 (05) : 733 - 744
  • [8] Transgenic mouse model for studying the transcriptional activity of the p53 protein: Age- and tissue-dependent changes in radiation-induced activation during embryogenesis
    Gottlieb, E
    Haffner, R
    King, A
    Asher, G
    Gruss, P
    Lonai, P
    Oren, M
    [J]. EMBO JOURNAL, 1997, 16 (06) : 1381 - 1390
  • [9] SPONTANEOUS AND CARCINOGEN-INDUCED TUMORIGENESIS IN P53-DEFICIENT MICE
    HARVEY, M
    MCARTHUR, MJ
    MONTGOMERY, CA
    BUTEL, JS
    BRADLEY, A
    DONEHOWER, LA
    [J]. NATURE GENETICS, 1993, 5 (03) : 225 - 229
  • [10] Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias
    Hayette, S
    Thomas, X
    Bertrand, Y
    Tigaud, I
    Callanan, M
    Thiebaut, A
    Charrin, C
    Archimbaud, E
    Magaud, JP
    Rimokh, R
    [J]. LEUKEMIA, 1997, 11 (10) : 1696 - 1699